Background. A 48-year-old man presented with diarrhea, flushing, abdominal pain and weight loss of 10 kg over a 6-month period. He subsequently developed dyspnea on exertion. Diagnosis. Carcinoid ...

A new report by FutureWise Research highlights a powerful trend in modern medicine: as awareness and innovation rise, hope grows for people living with Carcinoid Tumor Syndrome Management Market—a ...

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon ...

GI stromal tumors (GISTs) are neoplasms with widely variable malignant potential that arise from the GI tract, most frequently in the stomach. Their annual incidence is approximately 10 per million. 1 ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

Patients with newly diagnosed gastric or gastroesophageal junction (GEJ) cancer who received the PD-L1 inhibitor durvalumab ...

T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited to the pancreas and size 2–4 cm T3 Tumor limited to the pancreas and size >4 cm or invading duodenum or bile duct T4 Tumor ...

The final, formatted version of the article will be published soon. BackgroundRecent evidence suggests that inflammation is relevant to carcinogenesis and tumor progression. Biomarkers of the ...

metastases or an active primary CNS cancer * History or presence of clinically relevant cardiovascular abnormalities * Major surgery within 28 days of the first dose of study drug * Had systemic ...